The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA
The future of public health in an “RNA world” is on trial in a trade secrecy dispute worth $950 million.
Intellectual Property
-
Read more: The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA -
Read more: Proposed Amendments Would Make Foreign Investment in India’s Biological Resources Easier Proposed Amendments Would Make Foreign Investment in India’s Biological Resources Easier
Indian lawmakers are currently debating amendments that would make it easier for foreign investors to develop products from native biological resources.
-
Read more: Reclaiming Global Public Health Reclaiming Global Public Health
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
-
Read more: No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.
-
Read more: COVID-19, Patents, and Trade Secrets COVID-19, Patents, and Trade Secrets
Has the global distribution of COVID-19 vaccines been impacted by patent rights? David Gindler and Jasper L. Tran argue that the story is complicated.
-
Read more: Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation
We are excited to welcome our inaugural group of affiliated researchers for the Project on Psychedelics Law and Regulation (POPLAR).
-
Read more: COVID ‘Compromise’ on International IP Underscores Need for New Approach COVID ‘Compromise’ on International IP Underscores Need for New Approach
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.
-
Read more: Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics
Research funding contracts can help to safeguard against inequities in global allocation and distribution of lifesaving diagnostics, drugs, and vaccines.
-
Read more: Graduate Students’ Curricula Should Include Intellectual Property Graduate Students’ Curricula Should Include Intellectual Property
Science and engineering graduate students’ curricula should include cross-disciplinary studies in intellectual property (IP).
-
Read more: The Risk of Pervasive Trade Secret Practices Within the Life Sciences The Risk of Pervasive Trade Secret Practices Within the Life Sciences
Trade secrets offer a number of benefits for life sciences companies compared to patents, such as theoretical indefinite intellectual property protection.
